|
|
The function and regulation of OTU deubiquitinases |
Jiansen Du1, Lin Fu1, Yingli Sui1, Lingqiang Zhang2,3() |
1. Institute of Chronic Disease, Qingdao Municipal Hospital, Qingdao University, Qingdao 266000, China 2. State Key Laboratory of Proteomics, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, Beijing 100850, China 3. Peixian People’s Hospital, Xuzhou 221600, China |
|
|
Abstract Post-translational modification of cellular proteins by ubiquitin regulates numerous cellular processes, including cell division, immune responses, and apoptosis. Ubiquitin-mediated control over these processes can be reversed by deubiquitinases (DUBs), which remove ubiquitin from target proteins and depolymerize polyubiquitin chains. Recently, much progress has been made in the DUBs. In humans, the ovarian tumor protease (OTU) subfamily of DUBs includes 16 members, most of which mediate cell signaling cascades. These OTUs show great variation in structure and function, which display a series of mechanistic features. In this review, we provide a comprehensive analysis of current progress in character, structure and function of OTUs, such as the substrate specificity and catalytic activity regulation. Then we discuss the relationship between some diseases and OTUs. Finally, we summarize the structure of viral OTUs and their function in immune escape and viral survival. Despite the challenges, OTUs might provide new therapeutic targets, due to their involvement in key regulatory processes.
|
Keywords
ubiquitin
OTU deubiquitinases
structure
function
regulation
|
Corresponding Author(s):
Lingqiang Zhang
|
Just Accepted Date: 15 November 2019
Online First Date: 25 December 2019
Issue Date: 12 October 2020
|
|
1 |
D Komander, M Rape. The ubiquitin code. Annu Rev Biochem 2012; 81(1): 203–229
https://doi.org/10.1146/annurev-biochem-060310-170328
pmid: 22524316
|
2 |
J Heideker, IE Wertz. DUBs, the regulation of cell identity and disease. Biochem J 2015; 467(1): 191
https://doi.org/10.1042/bj4670191
pmid: 25793419
|
3 |
TE Mevissen, MK Hospenthal, PP Geurink, PR Elliott, M Akutsu, N Arnaudo, R Ekkebus, Y Kulathu, T Wauer, F El Oualid, SM Freund, H Ovaa, D Komander. OTU deubiquitinases reveal mechanisms of linkage specificity and enable ubiquitin chain restriction analysis. Cell 2013; 154(1): 169–184
https://doi.org/10.1016/j.cell.2013.05.046
pmid: 23827681
|
4 |
KN Swatek, D Komander. Ubiquitin modifications. Cell Res 2016; 26(4): 399–422
https://doi.org/10.1038/cr.2016.39
pmid: 27012465
|
5 |
S Nakada, I Tai, S Panier, A Al-Hakim, S Iemura, YC Juang, L O’Donnell, A Kumakubo, M Munro, F Sicheri, AC Gingras, T Natsume, T Suda, D Durocher. Non-canonical inhibition of DNA damage-dependent ubiquitination by OTUB1. Nature 2010; 466(7309): 941–946
https://doi.org/10.1038/nature09297
pmid: 20725033
|
6 |
L Yuan, Y Lv, H Li, H Gao, S Song, Y Zhang, G Xing, X Kong, L Wang, Y Li, T Zhou, D Gao, ZX Xiao, Y Yin, W Wei, F He, L Zhang. Deubiquitylase OTUD3 regulates PTEN stability and suppresses tumorigenesis. Nat Cell Biol 2015; 17(9): 1169–1181
https://doi.org/10.1038/ncb3218
pmid: 26280536
|
7 |
OW Huang, X Ma, J Yin, J Flinders, T Maurer, N Kayagaki, Q Phung, I Bosanac, D Arnott, VM Dixit, SG Hymowitz, MA Starovasnik, AG Cochran. Phosphorylation-dependent activity of the deubiquitinase DUBA. Nat Struct Mol Biol 2012; 19(2): 171–175
https://doi.org/10.1038/nsmb.2206
pmid: 22245969
|
8 |
PN Duy, NT Thuy, BK Trang, NH Giang, NTH Van, NT Xuan. Regulation of NF-kB- and STAT1-mediated plasmacytoid dendritic cell functions by A20. PLoS One 2019; 14(9): e0222697
https://doi.org/10.1371/journal.pone.0222697
pmid: 31545817
|
9 |
H Hu, GC Brittain, JH Chang, N Puebla-Osorio, J Jin, A Zal, Y Xiao, X Cheng, M Chang, YX Fu, T Zal, C Zhu, SC Sun. OTUD7B controls non-canonical NF-kB activation through deubiquitination of TRAF3. Nature 2013; 494(7437): 371–374
https://doi.org/10.1038/nature11831
pmid: 23334419
|
10 |
RB Damgaard, JA Walker, P Marco-Casanova, NV Morgan, HL Titheradge, PR Elliott, D McHale, ER Maher, ANJ McKenzie, D Komander. The deubiquitinase OTULIN is an essential negative regulator of inflammation and autoimmunity. Cell 2016; 166(5): 1215–1230e20
|
11 |
S Vijay-Kumar, CE Bugg, WJ Cook. Structure of ubiquitin refined at 1.8 Å resolution. J Mol Biol 1987; 194(3): 531–544
https://doi.org/10.1016/0022-2836(87)90679-6
pmid: 3041007
|
12 |
C Kiel, L Serrano. The ubiquitin domain superfold: structure-based sequence alignments and characterization of binding epitopes. J Mol Biol 2006; 355(4): 821–844
https://doi.org/10.1016/j.jmb.2005.10.010
pmid: 16310215
|
13 |
H Walden, MS Podgorski, BA Schulman. Insights into the ubiquitin transfer cascade from the structure of the activating enzyme for NEDD8. Nature 2003; 422(6929): 330–334
https://doi.org/10.1038/nature01456
pmid: 12646924
|
14 |
M Hu, P Li, M Li, W Li, T Yao, JW Wu, W Gu, RE Cohen, Y Shi. Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde. Cell 2002; 111(7): 1041–1054
https://doi.org/10.1016/S0092-8674(02)01199-6
pmid: 12507430
|
15 |
FE Reyes-Turcu, JR Horton, JE Mullally, A Heroux, X Cheng, KD Wilkinson. The ubiquitin binding domain ZnF UBP recognizes the C-terminal diglycine motif of unanchored ubiquitin. Cell 2006; 124(6): 1197–1208
https://doi.org/10.1016/j.cell.2006.02.038
pmid: 16564012
|
16 |
R Yau, M Rape. The increasing complexity of the ubiquitin code. Nat Cell Biol 2016; 18(6): 579–586
https://doi.org/10.1038/ncb3358
pmid: 27230526
|
17 |
J Peng, D Schwartz, JE Elias, CC Thoreen, D Cheng, G Marsischky, J Roelofs, D Finley, SP Gygi. A proteomics approach to understanding protein ubiquitination. Nat Biotechnol 2003; 21(8): 921–926
https://doi.org/10.1038/nbt849
pmid: 12872131
|
18 |
P Xu, DM Duong, NT Seyfried, D Cheng, Y Xie, J Robert, J Rush, M Hochstrasser, D Finley, J Peng. Quantitative proteomics reveals the function of unconventional ubiquitin chains in proteasomal degradation. Cell 2009; 137(1): 133–145
https://doi.org/10.1016/j.cell.2009.01.041
pmid: 19345192
|
19 |
DL Swaney, P Beltrao, L Starita, A Guo, J Rush, S Fields, NJ Krogan, J Villén. Global analysis of phosphorylation and ubiquitylation cross-talk in protein degradation. Nat Methods 2013; 10(7): 676–682
https://doi.org/10.1038/nmeth.2519
pmid: 23749301
|
20 |
F Ohtake, Y Saeki, K Sakamoto, K Ohtake, H Nishikawa, H Tsuchiya, T Ohta, K Tanaka, J Kanno. Ubiquitin acetylation inhibits polyubiquitin chain elongation. EMBO Rep 2015; 16(2): 192–201
https://doi.org/10.15252/embr.201439152
pmid: 25527407
|
21 |
J Cui, Q Yao, S Li, X Ding, Q Lu, H Mao, L Liu, N Zheng, S Chen, F Shao. Glutamine deamidation and dysfunction of ubiquitin/NEDD8 induced by a bacterial effector family. Science 2010; 329(5996): 1215–1218
https://doi.org/10.1126/science.1193844
pmid: 20688984
|
22 |
TET Mevissen, D Komander. Mechanisms of deubiquitinase specificity and regulation. Annu Rev Biochem 2017; 86(1): 159–192
https://doi.org/10.1146/annurev-biochem-061516-044916
pmid: 28498721
|
23 |
BA Schulman, JW Harper. Ubiquitin-like protein activation by E1 enzymes: the apex for downstream signalling pathways. Nat Rev Mol Cell Biol 2009; 10(5): 319–331
https://doi.org/10.1038/nrm2673
pmid: 19352404
|
24 |
Y Ye, M Rape. Building ubiquitin chains: E2 enzymes at work. Nat Rev Mol Cell Biol 2009; 10(11): 755–764
https://doi.org/10.1038/nrm2780
pmid: 19851334
|
25 |
L Buetow, DT Huang. Structural insights into the catalysis and regulation of E3 ubiquitin ligases. Nat Rev Mol Cell Biol 2016; 17(10): 626–642
https://doi.org/10.1038/nrm.2016.91
pmid: 27485899
|
26 |
MJ Clague, I Barsukov, JM Coulson, H Liu, DJ Rigden, S Urbé. Deubiquitylases from genes to organism. Physiol Rev 2013; 93(3): 1289–1315
https://doi.org/10.1152/physrev.00002.2013
pmid: 23899565
|
27 |
D Komander, MJ Clague, S Urbé. Breaking the chains: structure and function of the deubiquitinases. Nat Rev Mol Cell Biol 2009; 10(8): 550–563
https://doi.org/10.1038/nrm2731
pmid: 19626045
|
28 |
FE Reyes-Turcu, KH Ventii, KD Wilkinson. Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes. Annu Rev Biochem 2009; 78(1): 363–397
https://doi.org/10.1146/annurev.biochem.78.082307.091526
pmid: 19489724
|
29 |
AY Amerik, M Hochstrasser. Mechanism and function of deubiquitinating enzymes. Biochim Biophys Acta 2004; 1695(1–3): 189–207
https://doi.org/10.1016/j.bbamcr.2004.10.003
pmid: 15571815
|
30 |
MJ Clague, S Urbé, D Komander. Breaking the chains: deubiquitylating enzyme specificity begets function. Nat Rev Mol Cell Biol 2019; 20(6): 338–352
https://doi.org/10.1038/s41580-019-0099-1
pmid: 30733604
|
31 |
Y Ye, G Blaser, MH Horrocks, MJ Ruedas-Rama, S Ibrahim, AA Zhukov, A Orte, D Klenerman, SE Jackson, D Komander. Ubiquitin chain conformation regulates recognition and activity of interacting proteins. Nature 2012; 492(7428): 266–270
https://doi.org/10.1038/nature11722
pmid: 23201676
|
32 |
M Renatus, SG Parrado, A D’Arcy, U Eidhoff, B Gerhartz, U Hassiepen, B Pierrat, R Riedl, D Vinzenz, S Worpenberg, M Kroemer. Structural basis of ubiquitin recognition by the deubiquitinating protease USP2. Structure 2006; 14(8): 1293–1302
https://doi.org/10.1016/j.str.2006.06.012
pmid: 16905103
|
33 |
JB Schaefer, DO Morgan. Protein-linked ubiquitin chain structure restricts activity of deubiquitinating enzymes. J Biol Chem 2011; 286(52): 45186–45196
https://doi.org/10.1074/jbc.M111.310094
pmid: 22072716
|
34 |
MJ Clague, JM Coulson, S Urbé. Cellular functions of the DUBs. J Cell Sci 2012; 125(Pt 2): 277–286
https://doi.org/10.1242/jcs.090985
pmid: 22357969
|
35 |
KS Makarova, L Aravind, EV Koonin. A novel superfamily of predicted cysteine proteases from eukaryotes, viruses and Chlamydia pneumoniae. Trends Biochem Sci 2000; 25(2): 50–52
https://doi.org/10.1016/S0968-0004(99)01530-3
pmid: 10664582
|
36 |
C Rodesch, PK Geyer, JS Patton, E Bae, RN Nagoshi. Developmental analysis of the ovarian tumor gene during Drosophila oogenesis. Genetics 1995; 141(1): 191–202
pmid: 8536967
|
37 |
GL Sass, AR Comer, LL Searles. The ovarian tumor protein isoforms of Drosophila melanogaster exhibit differences in function, expression, and localization. Dev Biol 1995; 167(1): 201–212
https://doi.org/10.1006/dbio.1995.1017
pmid: 7851643
|
38 |
MY Balakirev, SO Tcherniuk, M Jaquinod, J Chroboczek. Otubains: a new family of cysteine proteases in the ubiquitin pathway. EMBO Rep 2003; 4(5): 517–522
https://doi.org/10.1038/sj.embor.embor824
pmid: 12704427
|
39 |
MH Nanao, SO Tcherniuk, J Chroboczek, O Dideberg, A Dessen, MY Balakirev. Crystal structure of human otubain 2. EMBO Rep 2004; 5(8): 783–788
https://doi.org/10.1038/sj.embor.7400201
pmid: 15258613
|
40 |
SC Lin, JY Chung, B Lamothe, K Rajashankar, M Lu, YC Lo, AY Lam, BG Darnay, H Wu. Molecular basis for the unique deubiquitinating activity of the NF-κB inhibitor A20. J Mol Biol 2008; 376(2): 526–540
https://doi.org/10.1016/j.jmb.2007.11.092
pmid: 18164316
|
41 |
Y Kulathu. Novel diubiquitin probes expand the chemical toolkit to study DUBs. Cell Chem Biol 2016; 23(4): 432–434
https://doi.org/10.1016/j.chembiol.2016.04.001
pmid: 27105279
|
42 |
MJ Edelmann, A Iphöfer, M Akutsu, M Altun, K di Gleria, HB Kramer, E Fiebiger, S Dhe-Paganon, BM Kessler. Structural basis and specificity of human otubain 1-mediated deubiquitination. Biochem J 2009; 418(2): 379–390
https://doi.org/10.1042/BJ20081318
pmid: 18954305
|
43 |
T Wang, L Yin, EM Cooper, MY Lai, S Dickey, CM Pickart, D Fushman, KD Wilkinson, RE Cohen, C Wolberger. Evidence for bidentate substrate binding as the basis for the K48 linkage specificity of otubain 1. J Mol Biol 2009; 386(4): 1011–1023
https://doi.org/10.1016/j.jmb.2008.12.085
pmid: 19211026
|
44 |
JD Licchesi, J Mieszczanek, TE Mevissen, TJ Rutherford, M Akutsu, S Virdee, F El Oualid, JW Chin, H Ovaa, M Bienz, D Komander. An ankyrin-repeat ubiquitin-binding domain determines TRABID’s specificity for atypical ubiquitin chains. Nat Struct Mol Biol 2012; 19(1): 62–71
https://doi.org/10.1038/nsmb.2169
pmid: 22157957
|
45 |
K Keusekotten, PR Elliott, L Glockner, BK Fiil, RB Damgaard, Y Kulathu, T Wauer, MK Hospenthal, M Gyrd-Hansen, D Krappmann, K Hofmann, D Komander. OTULIN antagonizes LUBAC signaling by specifically hydrolyzing Met1-linked polyubiquitin. Cell 2013; 153(6): 1312–1326
https://doi.org/10.1016/j.cell.2013.05.014
pmid: 23746843
|
46 |
D Komander, D Barford. Structure of the A20 OTU domain and mechanistic insights into deubiquitination. Biochem J 2008; 409(1): 77–85
https://doi.org/10.1042/BJ20071399
pmid: 17961127
|
47 |
DA Boudreaux, J Chaney, TK Maiti, C Das. Contribution of active site glutamine to rate enhancement in ubiquitin C-terminal hydrolases. FEBS J 2012; 279(6): 1106–1118
https://doi.org/10.1111/j.1742-4658.2012.08507.x
pmid: 22284438
|
48 |
AC Storer, R Ménard. Catalytic mechanism in papain family of cysteine peptidases. Methods Enzymol 1994; 244: 486–500
https://doi.org/10.1016/0076-6879(94)44035-2
pmid: 7845227
|
49 |
Z Zhang, J Du, S Wang, L Shao, K Jin, F Li, B Wei, W Ding, P Fu, H van Dam, A Wang, J Jin, C Ding, B Yang, M Zheng, XH Feng, KL Guan, L Zhang. OTUB2 promotes cancer metastasis via Hippo-independent activation of YAP and TAZ. Mol Cell 2019; 73(1): 7–21.e7
|
50 |
K Kato, K Nakajima, A Ui, Y Muto-Terao, H Ogiwara, S Nakada. Fine-tuning of DNA damage-dependent ubiquitination by OTUB2 supports the DNA repair pathway choice. Mol Cell 2014; 53(4): 617–630
https://doi.org/10.1016/j.molcel.2014.01.030
pmid: 24560272
|
51 |
Y Li, JY Yang, X Xie, Z Jie, L Zhang, J Shi, D Lin, M Gu, X Zhou, HS Li, SS Watowich, A Jain, S Yun Jung, J Qin, X Cheng, SC Sun. Preventing abnormal NF-kB activation and autoimmunity by Otub1-mediated p100 stabilization. Cell Res 2019; 29(6): 474–485
https://doi.org/10.1038/s41422-019-0174-3
pmid: 31086255
|
52 |
X Zhou, J Yu, X Cheng, B Zhao, GC Manyam, L Zhang, K Schluns, P Li, J Wang, SC Sun. The deubiquitinase Otub1 controls the activation of CD8+ T cells and NK cells by regulating IL-15-mediated priming. Nat Immunol 2019; 20(7): 879–889
https://doi.org/10.1038/s41590-019-0405-2
pmid: 31182807
|
53 |
R Wiener, X Zhang, T Wang, C Wolberger. The mechanism of OTUB1-mediated inhibition of ubiquitination. Nature 2012; 483(7391): 618–622
https://doi.org/10.1038/nature10911
pmid: 22367539
|
54 |
Z Zhang, Y Fan, F Xie, H Zhou, K Jin, L Shao, W Shi, P Fang, B Yang, H van Dam, P Ten Dijke, X Zheng, X Yan, J Jia, M Zheng, J Jin, C Ding, S Ye, F Zhou, L Zhang. Breast cancer metastasis suppressor OTUD1 deubiquitinates SMAD7. Nat Commun 2017; 8(1): 2116
https://doi.org/10.1038/s41467-017-02029-7
pmid: 29235476
|
55 |
F Yao, Z Xiao, Y Sun, L Ma. SKP2 and OTUD1 govern non-proteolytic ubiquitination of YAP that promotes YAP nuclear localization and activity. Cell Stress 2018; 2(9): 233–235
https://doi.org/10.15698/cst2018.09.153
pmid: 31225491
|
56 |
Y Kim, W Kim, Y Song, JR Kim, K Cho, H Moon, SW Ro, E Seo, YM Ryu, SJ Myung, EH Jho. Deubiquitinase YOD1 potentiates YAP/TAZ activities through enhancing ITCH stability. Proc Natl Acad Sci USA 2017; 114(18): 4691–4696
https://doi.org/10.1073/pnas.1620306114
pmid: 28416659
|
57 |
G Schimmack, K Schorpp, K Kutzner, T Gehring, JK Brenke, K Hadian, D Krappmann. YOD1/TRAF6 association balances p62-dependent IL-1 signaling to NF-kB. eLife 2017; 6: e22416. doi:10.7554/eLife.22416
pmid: 28244869
|
58 |
J Zou, W Ma, J Li, R Littlejohn, H Zhou, IM Kim, DJR Fulton, W Chen, NL Weintraub, J Zhou, H Su. Neddylation mediates ventricular chamber maturation through repression of Hippo signaling. Proc Natl Acad Sci USA 2018; 115(17): E4101–E4110
https://doi.org/10.1073/pnas.1719309115
pmid: 29632206
|
59 |
T Du, H Li, Y Fan, L Yuan, X Guo, Q Zhu, Y Yao, X Li, C Liu, X Yu, Z Liu, CP Cui, C Han, L Zhang. The deubiquitylase OTUD3 stabilizes GRP78 and promotes lung tumorigenesis. Nat Commun 2019; 10(1): 2914
https://doi.org/10.1038/s41467-019-10824-7
pmid: 31266968
|
60 |
Y Zhao, MC Majid, JM Soll, JR Brickner, S Dango, N Mosammaparast. Noncanonical regulation of alkylation damage resistance by the OTUD4 deubiquitinase. EMBO J 2015; 34(12): 1687–1703
https://doi.org/10.15252/embj.201490497
pmid: 25944111
|
61 |
Y Zhao, MC Mudge, JM Soll, RB Rodrigues, AK Byrum, EA Schwarzkopf, TR Bradstreet, SP Gygi, BT Edelson, N Mosammaparast. OTUD4 is a phospho-activated K63 deubiquitinase that regulates MyD88-dependent signaling. Mol Cell 2018; 69(3): 505–516.e5
|
62 |
SY Park, HK Choi, Y Choi, S Kwak, KC Choi, HG Yoon. Deubiquitinase OTUD5 mediates the sequential activation of PDCD5 and p53 in response to genotoxic stress. Cancer Lett 2015; 357(1): 419–427
https://doi.org/10.1016/j.canlet.2014.12.005
pmid: 25499082
|
63 |
F Li, Q Sun, K Liu, H Han, N Lin, Z Cheng, Y Cai, F Tian, Z Mao, T Tong, W Zhao. The deubiquitinase OTUD5 regulates Ku80 stability and non-homologous end joining. Cell Mol Life Sci 2019; 76(19): 3861–3873
https://doi.org/10.1007/s00018-019-03094-5
pmid: 30980112
|
64 |
SY Kim, SK Kwon, SY Lee, KH Baek. Ubiquitin-specific peptidase 5 and ovarian tumor deubiquitinase 6A are differentially expressed in p53+/+ and p53−/− HCT116 cells. Int J Oncol 2018 Mar 5. [Epub ahead of print] doi: 10.3892/ijo.2018.4302
pmid: 29512757
|
65 |
A Sobol, C Askonas, S Alani, MJ Weber, V Ananthanarayanan, C Osipo, M Bocchetta. Deubiquitinase OTUD6B isoforms are important regulators of growth and proliferation. Mol Cancer Res 2017; 15(2): 117–127
https://doi.org/10.1158/1541-7786.MCR-16-0281-T
pmid: 27864334
|
66 |
Z Xu, L Pei, L Wang, F Zhang, X Hu, Y Gui. Snail1-dependent transcriptional repression of Cezanne2 in hepatocellular carcinoma. Oncogene 2014; 33(22): 2836–2845
https://doi.org/10.1038/onc.2013.243
pmid: 23792447
|
67 |
M Uddin, BK Unda, V Kwan, NT Holzapfel, SH White, L Chalil, M Woodbury-Smith, KS Ho, E Harward, N Murtaza, B Dave, G Pellecchia, L D’Abate, T Nalpathamkalam, S Lamoureux, J Wei, M Speevak, J Stavropoulos, KJ Hope, BW Doble, J Nielsen, ER Wassman, SW Scherer, KK Singh. OTUD7A regulates neurodevelopmental phenotypes in the 15q13.3 microdeletion syndrome. Am J Hum Genet 2018; 102(2): 278–295
https://doi.org/10.1016/j.ajhg.2018.01.006
pmid: 29395074
|
68 |
TET Mevissen, Y Kulathu, MPC Mulder, PP Geurink, SL Maslen, M Gersch, PR Elliott, JE Burke, BDM van Tol, M Akutsu, FE Oualid, M Kawasaki, SMV Freund, H Ovaa, D Komander. Molecular basis of Lys11-polyubiquitin specificity in the deubiquitinase Cezanne. Nature 2016; 538(7625): 402–405
https://doi.org/10.1038/nature19836
pmid: 27732584
|
69 |
CP Cui, Y Zhang, C Wang, F Yuan, H Li, Y Yao, Y Chen, C Li, W Wei, CH Liu, F He, Y Liu, L Zhang. Dynamic ubiquitylation of Sox2 regulates proteostasis and governs neural progenitor cell differentiation. Nat Commun 2018; 9(1): 4648
https://doi.org/10.1038/s41467-018-07025-z
pmid: 30405104
|
70 |
DD Lin, Y Shen, S Qiao, WW Liu, L Zheng, YN Wang, N Cui, YF Wang, S Zhao, JH Shi. Upregulation of OTUD7B (Cezanne) promotes tumor progression via AKT/VEGF pathway in lung squamous carcinoma and adenocarcinoma. Front Oncol 2019; 9: 862
https://doi.org/10.3389/fonc.2019.00862
pmid: 31572671
|
71 |
Y Kulathu, FJ Garcia, TE Mevissen, M Busch, N Arnaudo, KS Carroll, D Barford, D Komander. Regulation of A20 and other OTU deubiquitinases by reversible oxidation. Nat Commun 2013; 4(1): 1569
https://doi.org/10.1038/ncomms2567
pmid: 23463012
|
72 |
F Tokunaga, H Nishimasu, R Ishitani, E Goto, T Noguchi, K Mio, K Kamei, A Ma, K Iwai, O Nureki. Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-kB regulation. EMBO J 2012; 31(19): 3856–3870
https://doi.org/10.1038/emboj.2012.241
pmid: 23032187
|
73 |
I Bosanac, IE Wertz, B Pan, C Yu, S Kusam, C Lam, L Phu, Q Phung, B Maurer, D Arnott, DS Kirkpatrick, VM Dixit, SG Hymowitz. Ubiquitin binding to A20 ZnF4 is required for modulation of NF-kB signaling. Mol Cell 2010; 40(4): 548–557
https://doi.org/10.1016/j.molcel.2010.10.009
pmid: 21095585
|
74 |
MA Michel, PR Elliott, KN Swatek, M Simicek, JN Pruneda, JL Wagstaff, SM Freund, D Komander. Assembly and specific recognition of k29- and k33-linked polyubiquitin. Mol Cell 2015; 58(1): 95–109
https://doi.org/10.1016/j.molcel.2015.01.042
pmid: 25752577
|
75 |
Y Zhu, C Qu, X Hong, Y Jia, M Lin, Y Luo, F Lin, X Xie, X Xie, J Huang, Q Wu, X Qiu, D Piao, Y Xing, T Yu, Y Lu, Q Huang, C Yu, J Jin, Z Zhang. Trabid inhibits hepatocellular carcinoma growth and metastasis by cleaving RNF8-induced K63 ubiquitination of Twist1. Cell Death Differ 2019; 26(2): 306–320
https://doi.org/10.1038/s41418-018-0119-2
pmid: 29748601
|
76 |
PR Elliott, SV Nielsen, P Marco-Casanova, BK Fiil, K Keusekotten, N Mailand, SM Freund, M Gyrd-Hansen, D Komander. Molecular basis and regulation of OTULIN-LUBAC interaction. Mol Cell 2014; 54(3): 335–348
https://doi.org/10.1016/j.molcel.2014.03.018
pmid: 24726323
|
77 |
A Weber, PR Elliott, A Pinto-Fernandez, S Bonham, BM Kessler, D Komander, F El Oualid, D Krappmann. A linear diubiquitin-based probe for efficient and selective detection of the deubiquitinating enzyme OTULIN. Cell Chem Biol 2017; 24(10): 1299–1313.e7
|
78 |
M Zhao, K Song, W Hao, L Wang, G Patil, Q Li, L Xu, F Hua, B Fu, JC Schwamborn, ME Dorf, S Li. Non-proteolytic ubiquitination of OTULIN regulates NF-kB signaling pathway. J Mol Cell Biol 2019; mjz081
https://doi.org/10.1093/jmcb/mjz081
pmid: 31504727
|
79 |
YC Tsai, A Kotiya, E Kiris, M Yang, S Bavari, L Tessarollo, GA Oyler, AM Weissman. Deubiquitinating enzyme VCIP135 dictates the duration of botulinum neurotoxin type A intoxication. Proc Natl Acad Sci USA 2017; 114(26): E5158–E5166
https://doi.org/10.1073/pnas.1621076114
pmid: 28584101
|
80 |
X Zhang, H Zhang, Y Wang. Phosphorylation regulates VCIP135 function in Golgi membrane fusion during the cell cycle. J Cell Sci 2014; 127(Pt 1): 172–181
https://doi.org/10.1242/jcs.134668
pmid: 24163436
|
81 |
P Gao, F Wang, J Huo, D Wan, J Zhang, J Niu, J Wu, B Yu, T Sun. ALG13 deficiency associated with increased seizure susceptibility and severity. Neuroscience 2019; 409: 204–221
https://doi.org/10.1016/j.neuroscience.2019.03.009
pmid: 30872163
|
82 |
SC Lin, JY Chung, B Lamothe, K Rajashankar, M Lu, YC Lo, AY Lam, BG Darnay, H Wu. Molecular basis for the unique deubiquitinating activity of the NF-κB inhibitor A20. J Mol Biol 2008; 376(2): 526–540
https://doi.org/10.1016/j.jmb.2007.11.092
pmid: 18164316
|
83 |
L Zhao, X Wang, Y Yu, L Deng, L Chen, X Peng, C Jiao, G Gao, X Tan, W Pan, X Ge, P Wang. OTUB1 protein suppresses mTOR complex 1 (mTORC1) activity by deubiquitinating the mTORC1 inhibitor DEPTOR. J Biol Chem 2018; 293(13): 4883–4892
https://doi.org/10.1074/jbc.M117.809533
pmid: 29382726
|
84 |
S Piao, HZ Pei, B Huang, SH Baek. Ovarian tumor domain-containing protein 1 deubiquitinates and stabilizes p53. Cell Signal 2017; 33: 22–29
https://doi.org/10.1016/j.cellsig.2017.02.011
pmid: 28216291
|
85 |
L Zhang, J Liu, L Qian, Q Feng, X Wang, Y Yuan, Y Zuo, Q Cheng, Y Miao, T Guo, X Zheng, H Zheng. Induction of OTUD1 by RNA viruses potently inhibits innate immune responses by promoting degradation of the MAVS/TRAF3/TRAF6 signalosome. PLoS Pathog 2018; 14(5): e1007067
https://doi.org/10.1371/journal.ppat.1007067
pmid: 29734366
|
86 |
R Ernst, B Mueller, HL Ploegh, C Schlieker. The otubain YOD1 is a deubiquitinating enzyme that associates with p97 to facilitate protein dislocation from the ER. Mol Cell 2009; 36(1): 28–38
https://doi.org/10.1016/j.molcel.2009.09.016
pmid: 19818707
|
87 |
C Papadopoulos, P Kirchner, M Bug, D Grum, L Koerver, N Schulze, R Poehler, A Dressler, S Fengler, K Arhzaouy, V Lux, M Ehrmann, CC Weihl, H Meyer. VCP/p97 cooperates with YOD1, UBXD1 and PLAA to drive clearance of ruptured lysosomes by autophagy. EMBO J 2017; 36(2): 135–150
https://doi.org/10.15252/embj.201695148
pmid: 27753622
|
88 |
R Das, L Schwintzer, S Vinopal, E Aguado Roca, M Sylvester, AM Oprisoreanu, S Schoch, F Bradke, M Broemer. New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. J Cell Sci 2019; 132(12): jcs229252
https://doi.org/10.1242/jcs.229252
pmid: 31138677
|
89 |
N Kayagaki, Q Phung, S Chan, R Chaudhari, C Quan, KM O’Rourke, M Eby, E Pietras, G Cheng, JF Bazan, Z Zhang, D Arnott, VM Dixit. DUBA: a deubiquitinase that regulates type I interferon production. Science 2007; 318(5856): 1628–1632
https://doi.org/10.1126/science.1145918
pmid: 17991829
|
90 |
A de Vivo, A Sanchez, J Yegres, J Kim, S Emly, Y Kee. The OTUD5-UBR5 complex regulates FACT-mediated transcription at damaged chromatin. Nucleic Acids Res 2019; 47(2): 729–746
https://doi.org/10.1093/nar/gky1219
pmid: 30508113
|
91 |
T Santiago-Sim, LC Burrage, F Ebstein, MJ Tokita, M Miller, W Bi, AA Braxton, JA Rosenfeld, M Shahrour, A Lehmann, B Cogné, S Küry, T Besnard, B Isidor, S Bézieau, I Hazart, H Nagakura, LL Immken, RO Littlejohn, E Roeder; EuroEPINOMICS RES Consortium Autosomal Recessive working group, S. Hande Caglayan, B Kara, K Hardies, S Weckhuysen, P May, JR Lemke, O Elpeleg, B Abu-Libdeh, KN James, JL Silhavy, MY Issa, MS Zaki, JG Gleeson, JR Seavitt, ME Dickinson, MC Ljungberg, S Wells, SJ Johnson, L Teboul, CM Eng, Y Yang, PM Kloetzel, JD Heaney, MA Walkiewicz, Z Afawi, R Balling, N Barisic, S Baulac, D Craiu, P De Jonghe, R Guerrero-Lopez, R Guerrini, I Helbig, H Hjalgrim, J Jähn, KM Klein, E Leguern, H Lerche, C Marini, H Muhle, F Rosenow, J Serratosa, K Sterbová, A Suls, RS Moller, P Striano, Y Weber, F Zara. Biallelic variants in OTUD6B cause an intellectual disability syndrome associated with seizures and dysmorphic features. Am J Hum Genet 2017; 100(4): 676–688
https://doi.org/10.1016/j.ajhg.2017.03.001
pmid: 28343629
|
92 |
M Takata, E Pachera, M Frank-Bertoncelj, A Kozlova, A Jüngel, ML Whitfield, S Assassi, M Calcagni, J de Vries-Bouwstra, TW Huizinga, F Kurreeman, G Kania, O Distler. OTUD6B-AS1 might be a novel regulator of apoptosis in systemic sclerosis. Front Immunol 2019; 10: 1100
https://doi.org/10.3389/fimmu.2019.01100
pmid: 31156645
|
93 |
G Wang, ZJ Zhang, WG Jian, PH Liu, W Xue, TD Wang, YY Meng, C Yuan, HM Li, YP Yu, ZX Liu, Q Wu, DM Zhang, C Zhang. Novel long noncoding RNA OTUD6B-AS1 indicates poor prognosis and inhibits clear cell renal cell carcinoma proliferation via the Wnt/b-catenin signaling pathway. Mol Cancer 2019; 18(1): 15
https://doi.org/10.1186/s12943-019-0942-1
pmid: 30670025
|
94 |
IE Wertz, KM O’Rourke, H Zhou, M Eby, L Aravind, S Seshagiri, P Wu, C Wiesmann, R Baker, DL Boone, A Ma, EV Koonin, VM Dixit. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling. Nature 2004; 430(7000): 694–699
https://doi.org/10.1038/nature02794
pmid: 15258597
|
95 |
C Mauro, F Pacifico, A Lavorgna, S Mellone, A Iannetti, R Acquaviva, S Formisano, P Vito, A Leonardi. ABIN-1 binds to NEMO/IKKγ and co-operates with A20 in inhibiting NF-κB. J Biol Chem 2006; 281(27): 18482–18488
https://doi.org/10.1074/jbc.M601502200
pmid: 16684768
|
96 |
B Skaug, J Chen, F Du, J He, A Ma, ZJ Chen. Direct, noncatalytic mechanism of IKK inhibition by A20. Mol Cell 2011; 44(4): 559–571
https://doi.org/10.1016/j.molcel.2011.09.015
pmid: 22099304
|
97 |
M Düwel, V Welteke, A Oeckinghaus, M Baens, B Kloo, U Ferch, BG Darnay, J Ruland, P Marynen, D Krappmann. A20 negatively regulates T cell receptor signaling to NF-κB by cleaving Malt1 ubiquitin chains. J Immunol 2009; 182(12): 7718–7728
https://doi.org/10.4049/jimmunol.0803313
pmid: 19494296
|
98 |
L Li, N Soetandyo, Q Wang, Y Ye. The zinc finger protein A20 targets TRAF2 to the lysosomes for degradation. Biochim Biophys Acta 2009; 1793(2): 346–353
https://doi.org/10.1016/j.bbamcr.2008.09.013
pmid: 18952128
|
99 |
C Yang, W Zang, Z Tang, Y Ji, R Xu, Y Yang, A Luo, B Hu, Z Zhang, Z Liu, X Zheng. A20/TNFAIP3 regulates the DNA damage response and mediates tumor cell resistance to DNA-damaging therapy. Cancer Res 2018; 78(4): 1069–1082
https://doi.org/10.1158/0008-5472.CAN-17-2143
pmid: 29233925
|
100 |
J Yin, W Chen, ES Chao, S Soriano, L Wang, W Wang, SE Cummock, H Tao, K Pang, Z Liu, FA Pereira, RC Samaco, HY Zoghbi, M Xue, CP Schaaf. Otud7a knockout mice recapitulate many neurological features of 15q13.3 microdeletion syndrome. Am J Hum Genet 2018; 102(2): 296–308
https://doi.org/10.1016/j.ajhg.2018.01.005
pmid: 29395075
|
101 |
A Bremm, S Moniz, J Mader, S Rocha, D Komander. Cezanne (OTUD7B) regulates HIF-1a homeostasis in a proteasome-independent manner. EMBO Rep 2014; 15(12): 1268–1277
https://doi.org/10.15252/embr.201438850
pmid: 25355043
|
102 |
B Wang, Z Jie, D Joo, A Ordureau, P Liu, W Gan, J Guo, J Zhang, BJ North, X Dai, X Cheng, X Bian, L Zhang, JW Harper, SC Sun, W Wei. TRAF2 and OTUD7B govern a ubiquitin-dependent switch that regulates mTORC2 signalling. Nature 2017; 545(7654): 365–369
https://doi.org/10.1038/nature22344
pmid: 28489822
|
103 |
A Luong, M Fragiadaki, J Smith, J Boyle, J Lutz, JL Dean, S Harten, M Ashcroft, SR Walmsley, DO Haskard, PH Maxwell, H Walczak, C Pusey, PC Evans. Cezanne regulates inflammatory responses to hypoxia in endothelial cells by targeting TRAF6 for deubiquitination. Circ Res 2013; 112(12): 1583–1591
https://doi.org/10.1161/CIRCRESAHA.111.300119
pmid: 23564640
|
104 |
H Tran, F Hamada, T Schwarz-Romond, M Bienz. Trabid, a new positive regulator of Wnt-induced transcription with preference for binding and cleaving K63-linked ubiquitin chains. Genes Dev 2008; 22(4): 528–542
https://doi.org/10.1101/gad.463208
pmid: 18281465
|
105 |
SW Bai, MT Herrera-Abreu, JL Rohn, V Racine, V Tajadura, N Suryavanshi, S Bechtel, S Wiemann, B Baum, AJ Ridley. Identification and characterization of a set of conserved and new regulators of cytoskeletal organization, cell morphology and migration. BMC Biol 2011; 9(1): 54
https://doi.org/10.1186/1741-7007-9-54
pmid: 21834987
|
106 |
J Jin, X Xie, Y Xiao, H Hu, Q Zou, X Cheng, SC Sun. Epigenetic regulation of the expression of Il12 and Il23 and autoimmune inflammation by the deubiquitinase Trabid. Nat Immunol 2016; 17(3): 259–268
https://doi.org/10.1038/ni.3347
pmid: 26808229
|
107 |
IS Afonina, R Beyaert. Trabid epigenetically drives expression of IL-12 and IL-23. Nat Immunol 2016; 17(3): 227–228
https://doi.org/10.1038/ni.3388
pmid: 26882254
|
108 |
E Rivkin, SM Almeida, DF Ceccarelli, YC Juang, TA MacLean, T Srikumar, H Huang, WH Dunham, R Fukumura, G Xie, Y Gondo, B Raught, AC Gingras, F Sicheri, SP Cordes. The linear ubiquitin-specific deubiquitinase gumby regulates angiogenesis. Nature 2013; 498(7454): 318–324
https://doi.org/10.1038/nature12296
pmid: 23708998
|
109 |
Q Zhou, X Yu, E Demirkaya, N Deuitch, D Stone, WL Tsai, HS Kuehn, H Wang, D Yang, YH Park, AK Ombrello, M Blake, T Romeo, EF Remmers, JJ Chae, JC Mullikin, F Güzel, JD Milner, M Boehm, SD Rosenzweig, M Gadina, SB Welch, S Özen, R Topaloglu, M Abinun, DL Kastner, I Aksentijevich. Biallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory disease. Proc Natl Acad Sci USA 2016; 113(36): 10127–10132
https://doi.org/10.1073/pnas.1612594113
pmid: 27559085
|
110 |
M Hrdinka, M Gyrd-Hansen. The Met1-linked ubiquitin machinery: emerging themes of (de)regulation. Mol Cell 2017; 68(2): 265–280
https://doi.org/10.1016/j.molcel.2017.09.001
pmid: 29053955
|
111 |
K Heger, KE Wickliffe, A Ndoja, J Zhang, A Murthy, DL Dugger, A Maltzman, F de Sousa E Melo, J Hung, Y Zeng, E Verschueren, DS Kirkpatrick, D Vucic, WP Lee, M Roose-Girma, RJ Newman, S Warming, YC Hsiao, LG Kőműves, JD Webster, K Newton, VM Dixit. OTULIN limits cell death and inflammation by deubiquitinating LUBAC. Nature 2018; 559(7712): 120–124
https://doi.org/10.1038/s41586-018-0256-2
pmid: 29950720
|
112 |
S Rutz, N Kayagaki, QT Phung, C Eidenschenk, R Noubade, X Wang, J Lesch, R Lu, K Newton, OW Huang, AG Cochran, M Vasser, BP Fauber, J DeVoss, J Webster, L Diehl, Z Modrusan, DS Kirkpatrick, JR Lill, W Ouyang, VM Dixit. Deubiquitinase DUBA is a post-translational brake on interleukin-17 production in T cells. Nature 2015; 518(7539): 417–421
https://doi.org/10.1038/nature13979
pmid: 25470037
|
113 |
IE Wertz, K Newton, D Seshasayee, S Kusam, C Lam, J Zhang, N Popovych, E Helgason, A Schoeffler, S Jeet, N Ramamoorthi, L Kategaya, RJ Newman, K Horikawa, D Dugger, W Sandoval, S Mukund, A Zindal, F Martin, C Quan, J Tom, WJ Fairbrother, M Townsend, S Warming, J DeVoss, J Liu, E Dueber, P Caplazi, WP Lee, CC Goodnow, M Balazs, K Yu, G Kolumam, VM Dixit. Phosphorylation and linear ubiquitin direct A20 inhibition of inflammation. Nature 2015; 528(7582): 370–375
https://doi.org/10.1038/nature16165
pmid: 26649818
|
114 |
JE Hutti, BE Turk, JM Asara, A Ma, LC Cantley, DW Abbott. IκB kinase β phosphorylates the K63 deubiquitinase A20 to cause feedback inhibition of the NF-κB pathway. Mol Cell Biol 2007; 27(21): 7451–7461
https://doi.org/10.1128/MCB.01101-07
pmid: 17709380
|
115 |
L Herhaus, AB Perez-Oliva, G Cozza, R Gourlay, S Weidlich, DG Campbell, LA Pinna, GP Sapkota. Casein kinase 2 (CK2) phosphorylates the deubiquitylase OTUB1 at Ser16 to trigger its nuclear localization. Sci Signal 2015; 8(372): ra35
https://doi.org/10.1126/scisignal.aaa0441
pmid: 25872870
|
116 |
P Leznicki, Y Kulathu. Mechanisms of regulation and diversification of deubiquitylating enzyme function. J Cell Sci 2017; 130(12): 1997–2006
https://doi.org/10.1242/jcs.201855
pmid: 28476940
|
117 |
XM Cotto-Rios, M Békés, J Chapman, B Ueberheide, TT Huang. Deubiquitinases as a signaling target of oxidative stress. Cell Reports 2012; 2(6): 1475–1484
https://doi.org/10.1016/j.celrep.2012.11.011
pmid: 23219552
|
118 |
JG Lee, K Baek, N Soetandyo, Y Ye. Reversible inactivation of deubiquitinases by reactive oxygen species in vitro and in cells. Nat Commun 2013; 4(1): 1568
https://doi.org/10.1038/ncomms2532
pmid: 23463011
|
119 |
SH Ross, Y Lindsay, ST Safrany, O Lorenzo, F Villa, R Toth, MJ Clague, CP Downes, NR Leslie. Differential redox regulation within the PTP superfamily. Cell Signal 2007; 19(7): 1521–1530
https://doi.org/10.1016/j.cellsig.2007.01.026
pmid: 17346927
|
120 |
K Enesa, K Ito, A Luong, I Thorbjornsen, C Phua, Y To, J Dean, DO Haskard, J Boyle, I Adcock, PC Evans. Hydrogen peroxide prolongs nuclear localization of NF-κB in activated cells by suppressing negative regulatory mechanisms. J Biol Chem 2008; 283(27): 18582–18590
https://doi.org/10.1074/jbc.M801312200
pmid: 18474597
|
121 |
R Wiener, AT DiBello, PM Lombardi, CM Guzzo, X Zhang, MJ Matunis, C Wolberger. E2 ubiquitin-conjugating enzymes regulate the deubiquitinating activity of OTUB1. Nat Struct Mol Biol 2013; 20(9): 1033–1039
https://doi.org/10.1038/nsmb.2655
pmid: 23955022
|
122 |
YC Juang, MC Landry, M Sanches, V Vittal, CC Leung, DF Ceccarelli, AR Mateo, JN Pruneda, DY Mao, RK Szilard, S Orlicky, M Munro, PS Brzovic, RE Klevit, F Sicheri, D Durocher. OTUB1 co-opts Lys48-linked ubiquitin recognition to suppress E2 enzyme function. Mol Cell 2012; 45(3): 384–397
https://doi.org/10.1016/j.molcel.2012.01.011
pmid: 22325355
|
123 |
Y Sato, A Yamagata, S Goto-Ito, K Kubota, R Miyamoto, S Nakada, S Fukai. Molecular basis of Lys-63-linked polyubiquitination inhibition by the interaction between human deubiquitinating enzyme OTUB1 and ubiquitin-conjugating enzyme UBC13. J Biol Chem 2012; 287(31): 25860–25868
https://doi.org/10.1074/jbc.M112.364752
pmid: 22679021
|
124 |
H Iha, JM Peloponese, L Verstrepen, G Zapart, F Ikeda, CD Smith, MF Starost, V Yedavalli, K Heyninck, I Dikic, R Beyaert, KT Jeang. Inflammatory cardiac valvulitis in TAX1BP1-deficient mice through selective NF-κB activation. EMBO J 2008; 27(4): 629–641
https://doi.org/10.1038/emboj.2008.5
pmid: 18239685
|
125 |
SG Hymowitz, IE Wertz. A20: from ubiquitin editing to tumour suppression. Nat Rev Cancer 2010; 10(5): 332–341
https://doi.org/10.1038/nrc2775
pmid: 20383180
|
126 |
B Coornaert, M Baens, K Heyninck, T Bekaert, M Haegman, J Staal, L Sun, ZJ Chen, P Marynen, R Beyaert. T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-κB inhibitor A20. Nat Immunol 2008; 9(3): 263–271
https://doi.org/10.1038/ni1561
pmid: 18223652
|
127 |
T Goncharov, K Niessen, MC de Almagro, A Izrael-Tomasevic, AV Fedorova, E Varfolomeev, D Arnott, K Deshayes, DS Kirkpatrick, D Vucic. OTUB1 modulates c-IAP1 stability to regulate signalling pathways. EMBO J 2013; 32(8): 1103–1114
https://doi.org/10.1038/emboj.2013.62
pmid: 23524849
|
128 |
S Urbé, H Liu, SD Hayes, C Heride, DJ Rigden, MJ Clague. Systematic survey of deubiquitinase localization identifies USP21 as a regulator of centrosome- and microtubule-associated functions. Mol Biol Cell 2012; 23(6): 1095–1103
https://doi.org/10.1091/mbc.e11-08-0668
pmid: 22298430
|
129 |
T Mueller, P Breuer, I Schmitt, J Walter, BO Evert, U Wüllner. CK2-dependent phosphorylation determines cellular localization and stability of ataxin-3. Hum Mol Genet 2009; 18(17): 3334–3343
https://doi.org/10.1093/hmg/ddp274
pmid: 19542537
|
130 |
CC Scholz, J Rodriguez, C Pickel, S Burr, JA Fabrizio, KA Nolan, P Spielmann, MA Cavadas, B Crifo, DN Halligan, JA Nathan, DJ Peet, RH Wenger, A Von Kriegsheim, EP Cummins, CT Taylor. FIH regulates cellular metabolism through hydroxylation of the deubiquitinase OTUB1. PLoS Biol 2016; 14(1): e1002347
https://doi.org/10.1371/journal.pbio.1002347
pmid: 26752685
|
131 |
L Soares, C Seroogy, H Skrenta, N Anandasabapathy, P Lovelace, CD Chung, E Engleman, CG Fathman. Two isoforms of otubain 1 regulate T cell anergy via GRAIL. Nat Immunol 2004; 5(1): 45–54
https://doi.org/10.1038/ni1017
pmid: 14661020
|
132 |
J Heideker, IE Wertz. DUBs, the regulation of cell identity and disease. Biochem J 2015; 465(1): 1–26
https://doi.org/10.1042/BJ20140496
pmid: 25631680
|
133 |
XX Sun, MS Dai. Deubiquitinating enzyme regulation of the p53 pathway: a lesson from Otub1. World J Biol Chem 2014; 5(2): 75–84
pmid: 24920999
|
134 |
J Luo, Z Lu, X Lu, L Chen, J Cao, S Zhang, Y Ling, X Zhou. OTUD5 regulates p53 stability by deubiquitinating p53. PLoS One 2013; 8(10): e77682
https://doi.org/10.1371/journal.pone.0077682
pmid: 24143256
|
135 |
M Notarbartolo, P Poma, D Perri, L Dusonchet, M Cervello, N D’Alessandro. Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-κB activation levels and in IAP gene expression. Cancer Lett 2005; 224(1): 53–65
https://doi.org/10.1016/j.canlet.2004.10.051
pmid: 15911101
|
136 |
EW Harhaj, VM Dixit. Regulation of NF-kB by deubiquitinases. Immunol Rev 2012; 246(1): 107–124
https://doi.org/10.1111/j.1600-065X.2012.01100.x
pmid: 22435550
|
137 |
EW Harhaj, VM Dixit. Deubiquitinases in the regulation of NF-kB signaling. Cell Res 2011; 21(1): 22–39
https://doi.org/10.1038/cr.2010.166
pmid: 21119682
|
138 |
W Wei, M Li, J Wang, F Nie, L Li. The E3 ubiquitin ligase ITCH negatively regulates canonical Wnt signaling by targeting dishevelled protein. Mol Cell Biol 2012; 32(19): 3903–3912
https://doi.org/10.1128/MCB.00251-12
pmid: 22826439
|
139 |
T Takiuchi, T Nakagawa, H Tamiya, H Fujita, Y Sasaki, Y Saeki, H Takeda, T Sawasaki, A Buchberger, T Kimura, K Iwai. Suppression of LUBAC-mediated linear ubiquitination by a specific interaction between LUBAC and the deubiquitinases CYLD and OTULIN. Genes Cells 2014; 19(3): 254–272
https://doi.org/10.1111/gtc.12128
pmid: 24461064
|
140 |
JM González-Navajas, J Law, KP Nguyen, M Bhargava, MP Corr, N Varki, L Eckmann, HM Hoffman, J Lee, E Raz. Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven antiinflammatory cytokine production. J Exp Med 2010; 207(13): 2799–2807
https://doi.org/10.1084/jem.20101326
pmid: 21115691
|
141 |
K Enesa, M Zakkar, H Chaudhury, A Luong, L Rawlinson, JC Mason, DO Haskard, JL Dean, PC Evans. NF-κB suppression by the deubiquitinating enzyme Cezanne: a novel negative feedback loop in pro-inflammatory signaling. J Biol Chem 2008; 283(11): 7036–7045
https://doi.org/10.1074/jbc.M708690200
pmid: 18178551
|
142 |
RS McNally, BK Davis, CM Clements, MA Accavitti-Loper, TW Mak, JP Ting. DJ-1 enhances cell survival through the binding of Cezanne, a negative regulator of NF-κB. J Biol Chem 2011; 286(6): 4098–4106
https://doi.org/10.1074/jbc.M110.147371
pmid: 21097510
|
143 |
Y Zhu, C Qu, X Hong, Y Jia, M Lin, Y Luo, F Lin, X Xie, X Xie, J Huang, Q Wu, X Qiu, D Piao, Y Xing, T Yu, Y Lu, Q Huang, C Yu, J Jin, Z Zhang. Trabid inhibits hepatocellular carcinoma growth and metastasis by cleaving RNF8-induced K63 ubiquitination of Twist1. Cell Death Differ 2019; 26(2): 306–320
https://doi.org/10.1038/s41418-018-0119-2
pmid: 29748601
|
144 |
J Choi, KH Baek. Cellular functions of stem cell factors mediated by the ubiquitin-proteasome system. Cell Mol Life Sci 2018; 75(11): 1947–1957
https://doi.org/10.1007/s00018-018-2770-7
pmid: 29423528
|
145 |
AP Chandrasekaran, B Suresh, HH Kim, KS Kim, S Ramakrishna. Concise review: fate determination of stem cells by deubiquitinating enzymes. Stem Cells 2017; 35(1): 9–16
https://doi.org/10.1002/stem.2446
pmid: 27341175
|
146 |
S Ramakrishna, KS Kim, KH Baek. Posttranslational modifications of defined embryonic reprogramming transcription factors. Cell Reprogram 2014; 16(2): 108–120
https://doi.org/10.1089/cell.2013.0077
pmid: 24568610
|
147 |
C Naujokat, T Sarić. Concise review: role and function of the ubiquitin-proteasome system in mammalian stem and progenitor cells. Stem Cells 2007; 25(10): 2408–2418
https://doi.org/10.1634/stemcells.2007-0255
pmid: 17641241
|
148 |
S Schubbert, J Jiao, M Ruscetti, J Nakashima, S Wu, H Lei, Q Xu, W Yi, H Zhu, H Wu. Methods for PTEN in stem cells and cancer stem cells. Methods Mol Biol 2016; 1388: 233–285
https://doi.org/10.1007/978-1-4939-3299-3_15
pmid: 27033080
|
149 |
S Duan, G Yuan, X Liu, R Ren, J Li, W Zhang, J Wu, X Xu, L Fu, Y Li, J Yang, W Zhang, R Bai, F Yi, K Suzuki, H Gao, CR Esteban, C Zhang, JC Izpisua Belmonte, Z Chen, X Wang, T Jiang, J Qu, F Tang, GH Liu. PTEN deficiency reprogrammes human neural stem cells towards a glioblastoma stem cell-like phenotype. Nat Commun 2015; 6(1): 10068
https://doi.org/10.1038/ncomms10068
pmid: 26632666
|
150 |
C Natarajan, K Takeda. Regulation of various DNA repair pathways by E3 ubiquitin ligases. J Cancer Res Ther 2017; 13(2): 157–169
https://doi.org/10.4103/0973-1482.204879
pmid: 28643728
|
151 |
P Schwertman, S Bekker-Jensen, N Mailand. Regulation of DNA double-strand break repair by ubiquitin and ubiquitin-like modifiers. Nat Rev Mol Cell Biol 2016; 17(6): 379–394
https://doi.org/10.1038/nrm.2016.58
pmid: 27211488
|
152 |
PJ Vlachostergios, A Patrikidou, DD Daliani, CN Papandreou. The ubiquitin-proteasome system in cancer, a major player in DNA repair. Part 1: post-translational regulation. J Cell Mol Med 2009; 13(9b 9B): 3006–3018
https://doi.org/10.1111/j.1582-4934.2009.00824.x
pmid: 19522845
|
153 |
Y Kee, TT Huang. Role of deubiquitinating enzymes in DNA repair. Mol Cell Biol 2016; 36(4): 524–544
https://doi.org/10.1128/MCB.00847-15
pmid: 26644404
|
154 |
MS Huen, R Grant, I Manke, K Minn, X Yu, MB Yaffe, J Chen. RNF8 transduces the DNA-damage signal via histone ubiquitylation and checkpoint protein assembly. Cell 2007; 131(5): 901–914
https://doi.org/10.1016/j.cell.2007.09.041
pmid: 18001825
|
155 |
NK Kolas, JR Chapman, S Nakada, J Ylanko, R Chahwan, FD Sweeney, S Panier, M Mendez, J Wildenhain, TM Thomson, L Pelletier, SP Jackson, D Durocher. Orchestration of the DNA-damage response by the RNF8 ubiquitin ligase. Science 2007; 318(5856): 1637–1640
https://doi.org/10.1126/science.1150034
pmid: 18006705
|
156 |
N Mailand, S Bekker-Jensen, H Faustrup, F Melander, J Bartek, C Lukas, J Lukas. RNF8 ubiquitylates histones at DNA double-strand breaks and promotes assembly of repair proteins. Cell 2007; 131(5): 887–900
https://doi.org/10.1016/j.cell.2007.09.040
pmid: 18001824
|
157 |
AC Jacomin, E Taillebourg, MO Fauvarque. Deubiquitinating enzymes related to autophagy: new therapeutic opportunities? Cells 2018; 7(8): E112
https://doi.org/10.3390/cells7080112
pmid: 30126257
|
158 |
FE Magraoui, C Reidick, HE Meyer, HW Platta. Autophagy-related deubiquitinating enzymes involved in health and disease. Cells 2015; 4(4): 596–621
https://doi.org/10.3390/cells4040596
pmid: 26445063
|
159 |
J Zinngrebe, A Montinaro, N Peltzer, H Walczak. Ubiquitin in the immune system. EMBO Rep 2014; 15(1): 28–45
https://doi.org/10.1002/embr.201338025
pmid: 24375678
|
160 |
BA Bailey-Elkin, PB van Kasteren, EJ Snijder, M Kikkert, BL Mark. Viral OTU deubiquitinases: a structural and functional comparison. PLoS Pathog 2014; 10(3): e1003894
https://doi.org/10.1371/journal.ppat.1003894
pmid: 24676359
|
161 |
PB van Kasteren, C Beugeling, DK Ninaber, N Frias-Staheli, S van Boheemen, A García-Sastre, EJ Snijder, M Kikkert. Arterivirus and nairovirus ovarian tumor domain-containing deubiquitinases target activated RIG-I to control innate immune signaling. J Virol 2012; 86(2): 773–785
https://doi.org/10.1128/JVI.06277-11
pmid: 22072774
|
162 |
N Frias-Staheli, NV Giannakopoulos, M Kikkert, SL Taylor, A Bridgen, J Paragas, JA Richt, RR Rowland, CS Schmaljohn, DJ Lenschow, EJ Snijder, A García-Sastre, HW Virgin 4th. Ovarian tumor domain-containing viral proteases evade ubiquitin- and ISG15-dependent innate immune responses. Cell Host Microbe 2007; 2(6): 404–416
https://doi.org/10.1016/j.chom.2007.09.014
pmid: 18078692
|
163 |
EJ Snijder, AL Wassenaar, WJ Spaan, AE Gorbalenya. The arterivirus Nsp2 protease. An unusual cysteine protease with primary structure similarities to both papain-like and chymotrypsin-like proteases. J Biol Chem 1995; 270(28): 16671–16676
https://doi.org/10.1074/jbc.270.28.16671
pmid: 7622476
|
164 |
BA Bailey-Elkin, RCM Knaap, M Kikkert, BL Mark. Structure and function of viral deubiquitinating enzymes. J Mol Biol 2017; 429(22): 3441–3470
https://doi.org/10.1016/j.jmb.2017.06.010
pmid: 28625850
|
165 |
W Feng, X Sun, N Shi, M Zhang, Z Guan, M Duan. Influenza a virus NS1 protein induced A20 contributes to viral replication by suppressing interferon-induced antiviral response. Biochem Biophys Res Commun 2017; 482(4): 1107–1113
https://doi.org/10.1016/j.bbrc.2016.11.166
pmid: 27914808
|
166 |
S Yokota, T Okabayashi, N Yokosawa, N Fujii. Measles virus P protein suppresses Toll-like receptor signal through up-regulation of ubiquitin-modifying enzyme A20. FASEB J 2008; 22(1): 74–83
https://doi.org/10.1096/fj.07-8976com
pmid: 17720800
|
167 |
S Li, H Zheng, AP Mao, B Zhong, Y Li, Y Liu, Y Gao, Y Ran, P Tien, HB Shu. Regulation of virus-triggered signaling by OTUB1- and OTUB2-mediated deubiquitination of TRAF3 and TRAF6. J Biol Chem 2010; 285(7): 4291–4297
https://doi.org/10.1074/jbc.M109.074971
pmid: 19996094
|
168 |
S Ning, JS Pagano. The A20 deubiquitinase activity negatively regulates LMP1 activation of IRF7. J Virol 2010; 84(12): 6130–6138
https://doi.org/10.1128/JVI.00364-10
pmid: 20392859
|
169 |
P Kumari, H Kumar. Viral deubiquitinases: role in evasion of anti-viral innate immunity. Crit Rev Microbiol 2018; 44(3): 304–317
https://doi.org/10.1080/1040841X.2017.1368999
pmid: 28885059
|
170 |
YC Guo, SW Zhang, Q Yuan. Deubiquitinating enzymes and bone remodeling. Stem Cells Int 2018; 2018: 3712083
https://doi.org/10.1155/2018/3712083
pmid: 30123285
|
171 |
G Mabilleau, D Chappard, A Sabokbar. Role of the A20-TRAF6 axis in lipopolysaccharide-mediated osteoclastogenesis. J Biol Chem 2011; 286(5): 3242–3249
https://doi.org/10.1074/jbc.M110.150300
pmid: 21127049
|
172 |
MJ Lee, E Lim, S Mun, S Bae, K Murata, LB Ivashkiv, KH Park-Min. Intravenous immunoglobulin (IVIG) attenuates TNF-induced pathologic bone resorption and suppresses osteoclastogenesis by inducing A20 expression. J Cell Physiol 2016; 231(2): 449–458
https://doi.org/10.1002/jcp.25091
pmid: 26189496
|
173 |
N Kumari, PW Jaynes, A Saei, PV Iyengar, JLC Richard, PJA Eichhorn. The roles of ubiquitin modifying enzymes in neoplastic disease. Biochim Biophys Acta Rev Cancer 2017; 1868(2): 456–483
https://doi.org/10.1016/j.bbcan.2017.09.002
pmid: 28923280
|
174 |
MS Ritorto, R Ewan, AB Perez-Oliva, A Knebel, SJ Buhrlage, M Wightman, SM Kelly, NT Wood, S Virdee, NS Gray, NA Morrice, DR Alessi, M Trost. Screening of DUB activity and specificity by MALDI-TOF mass spectrometry. Nat Commun 2014; 5(1): 4763
https://doi.org/10.1038/ncomms5763
pmid: 25159004
|
175 |
JA Harrigan, X Jacq, NM Martin, SP Jackson. Deubiquitylating enzymes and drug discovery: emerging opportunities. Nat Rev Drug Discov 2018; 17(1): 57–78
https://doi.org/10.1038/nrd.2017.152
pmid: 28959952
|
176 |
S Ji, Y Luo, Q Cai, Z Cao, Y Zhao, J Mei, C Li, P Xia, Z Xie, Z Xia, J Zhang, Q Sun, D Chen. LC domain-mediated coalescence is essential for Otu enzymatic activity to extend Drosophila lifespan. Mol Cell 2019; 74(2): 363–377.e5
https://doi.org/10.1016/j.molcel.2019.02.004
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|